Annual report 2021


The Fraunhofer IZI patent portfolio currently consists of 56 patent families (excluding patents held at Fraunhofer IZI-BB), which are available for use in collaborative projects as well as for direct marketing and licensing.

  • Technologies for the generation of pluripotent stem cells 
  • Methods for the diagnosis of infectious agents 
  • Methods for the diagnosis of cancer 
  • New treatment methods for cancer and other diseases 
  • New method for the prevention of graft-versus-host disease (GvHD) 
  • Method for immobilization of cells on surfaces 
  • Mineral compounds for prevention / therapy of kidney and intestinal diseases 
  • Method for the preparation of a leukocyte preparation 
  • Biomarkers and diagnostic systems for human or veterinary application 
  • RNA species for therapeutic and / or diagnostic use 
  • Methods and devices for point-of-care diagnostics 
  • Agents for the therapy of infectious as well as fibrotic and neurodegenerative diseases 
  • Methods for immunomodulation and treatment of immunological diseases 
  • Surface modification 
  • Inactivation of pathogens in the context of vaccine production and novel vaccine candidates 
  • Methods for transferring nucleic acids into cells 
  • Epitopes from food relevant for the development of allergies and methods for allergen extraction 
  • Methods for the transplantation of microbiomes 
  • Components of microscopic systems, especially light sheet microscopy 
  • Dialysis methods and novel components of dialysis systems 
  • Novel AAV vectors 
  • Method for improved image analysis


Thomas Tradler

Contact Press / Media

Dr. Thomas Tradler

Leitung Business Development und Patentmanagement

Fraunhofer-Institut für Zelltherapie und Immunologie IZI
Perlickstr. 1
04103 Leipzig

Phone +49 341 35536-9305

Fax +49 341 35536-89305